Top 10 Regencies/Cities with the Highest Number of Individuals Tested (Friday, November 11, 2022)

Based on national Covid-19 data recapitulation, 144 regencies/cities aggressively conducted Covid-19 tests above the national average. Data as of Friday, November 11, 2022, shows a national average of 0.42 tests per 1,000 people per week.

The top five, starting from the highest number of people tested per 1,000 people per week, are: Central Jakarta (5.56 people), South Jakarta (5.36 people), Balikpapan (4.54 people), East Jakarta (3.71 people), and West Jakarta (3.6 people).

Central Jakarta ranks first. With a population of 913,720, the number of people tested there is recorded at 5.56 per 1,000 people per week. The latest positive rate is 27.1 percent. The positive rate in this area increased compared to the previous week's percentage.

Next is South Jakarta. In an effort to combat the Covid-19 pandemic, the number of people tested was 5.36 per 1,000 people per week. The positive rate in this area was 23.98 percent, also higher than the previous week's ratio.

Balikpapan recorded 4.54 tests per 1,000 people per week. [The text repeats information for East and West Jakarta, which is redundant and omitted here for clarity].

In anticipation of the Omicron impact in various regions, based on national Covid-19 data recapitulation, 130 regencies/cities in Indonesia actively reported a higher daily number of people tested than before. Meanwhile, 171 other regencies/cities recorded a lower number of people tested compared to the previous week.

Areas outside Java with the highest number of people tested include Balikpapan, Badung, and Mimika, with 4.54, 2.68, and 2.21 people tested per 1,000 respectively.

Although Covid-19 transmission has decreased in some areas, the government urges everyone to continue reducing Covid-19 transmission by always wearing masks, maintaining distance, and frequently washing hands with soap and running water. Avoiding crowds and reducing mobility also contribute to suppressing the spread of the coronavirus.